New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 24, 2014
09:55 EDTNUVA, NUVA, SYK, SYK, ZMH, ZMH, GMED, GMED, JNJ, JNJ, KTWO, KTWO, LDRH, LDRH, MDT, MDT, MZOR, MZORLeerink medical devices analyst holds an analyst/industry conference call
Medical Devices Analyst Newitter, along with J. Scott Price, M.D., an orthopedic surgeon, discusses industry trends and new products currently being used for the spine, including fixation devices from NUVA, on an Analyst/Industry conference call. Other companies including GMED, JNJ, KTWO, LDRH, MDT, MZOR, SYK and ZMH may be discussed on the Analyst/Industry conference call to be held on July 25 at 10:30 am.
News For GMED;JNJ;KTWO;LDRH;MDT;MZOR;NUVA;SYK;ZMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
May 15, 2015
08:12 EDTMDTMedtronic Micra TPS meets initial safety, performance measures
Subscribe for More Information
07:35 EDTJNJMedivation price target raised to $148 from $128 at Leerink
Subscribe for More Information
May 14, 2015
14:54 EDTJNJJohnson & Johnson unit reports results of VENTURE-AF trial
Subscribe for More Information
13:58 EDTNUVANuVasive initiated with a Market Perform at Northland
Target $46.
13:55 EDTLDRHLDR Holding initiated with a Market Perform at Northland
Subscribe for More Information
13:55 EDTZMHZimmer initiated with an Outperform at Northland
Subscribe for More Information
13:54 EDTSYKStryker initiated with an Outperform at Northland
Subscribe for More Information
13:34 EDTMDTMedtronic: Micra transcatheter pacemaker meets initial safety measures in study
Subscribe for More Information
13:32 EDTKTWOK2M Group initiated with an Outperform at Northland
Target $31.
13:31 EDTMDTMedtronic says Evera MRI ICD study meets safety, efficacy endpoints
Subscribe for More Information
09:41 EDTMDT, JNJLeerink medical devices analyst holds a cardiology luncheon meeting
Subscribe for More Information
08:45 EDTZMHZimmer has a conference call hosted by JPMorgan
Subscribe for More Information
May 13, 2015
17:50 EDTJNJPharmacyclics to showcase new 'promising' Imbruvica data at ASCO
Pharmacyclics announced that ibrutinib, also known as Imbruvica, single-agent and combination data will be featured in seven oral and poster sessions at the 51st American Society of Clinical Oncology, ASCO, Annual Meeting being held May 29-June 2 in Chicago, IL. According to a statement from ASCO, Imbruvica data will also be included in the official press program during the meeting for the second time in two years. Imbruvica is jointly developed and commercialized by Pharmacyclics and Janssen Biotech, a Johnson & Johnson (JNJ) subsidiary. Data being presented include, among others, an oral presentation from the Phase III HELIOS study of ibrutinib in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia, a poster presentation of ibrutinib in steroid-dependent or refractory chronic graft-versus-host-disease as well as a dose adherence analysis of ibrutinib 420 mg administered to previously treated CLL patients. "We look forward to sharing promising data at this year's ASCO that examines the use of Imbruvica across a broad range of hematologic disease settings from our clinical studies," said Danelle James, M.D., M.S., Head of Oncology at Pharmacyclics.
07:31 EDTSYKHeart Rhythm Society to hold a conference
Heart Rhythm 2015 is being held in Boston on May 13-16.
May 12, 2015
11:43 EDTSYKStryker backs FY15 organic revenue growth of 5%-6%
Subscribe for More Information
10:02 EDTMDTMedtronic receives FDA approval and CE Mark for Advance ST cryoballoon
Subscribe for More Information
08:49 EDTLDRHLDR Holding management to meet with Piper Jaffray
Meetings to be held in Denver on May 13 and in San Francisco on May 14 hosted by Piper Jaffray.
May 11, 2015
17:58 EDTJNJJ&J's Janssen gets complete response letter regarding sNDA for Invega Sustenna
Subscribe for More Information
May 10, 2015
19:25 EDTJNJCourt rejects claim that drugmakers misled opiate patients, Bloomberg says
Subscribe for More Information
14:05 EDTJNJJohnson & Johnson shares may deliver double-digit returns, Barron's says
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use